1-3 of 3
Marco Andreani
Close
Sort by
Journal Articles

TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders

Clinical Trials & Observations
Pietro Merli, Daria Pagliara, Federica Galaverna, Giuseppina Li Pira, Marco Andreani, Giovanna Leone, Donato Amodio, Rita Maria Pinto, Alice Bertaina, Valentina Bertaina, Angela Mastronuzzi, Luisa Strocchio, Emilia Boccieri, Daniela Pende, Michela Falco, Matteo Di Nardo, Francesca Del Bufalo, Mattia Algeri, Franco Locatelli
Journal: Blood Advances
Blood Adv (2022) 6 (1): 281–292.
https://doi.org/10.1182/bloodadvances.2021005628
Published: 2022
Includes: Supplemental data
Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Clinical Trials & Observations
Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1333–1339.
https://doi.org/10.1182/bloodadvances.2020003707
Published: 2021
Journal Articles

Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ + /CD19 + -depleted grafts

Clinical Trials & Observations
Javid Gaziev, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Gioia De Angelis, Marco Marziali, Michela Ribersani, Cecilia Alfieri, Alessandro Lanti, Tiziana Galluccio, Gaspare Adorno, Marco Andreani
Journal: Blood Advances
Blood Adv (2018) 2 (3): 263–270.
https://doi.org/10.1182/bloodadvances.2017012005
Published: 2018